PHAT

Phathom Pharmaceuticals (PHAT) is the lead sponsor of 2 active clinical trials listed on ClinicalTrials.gov^[2], including 1 Phase 2^[1].

No Form 4 insider filings for PHAT were recorded at the SEC in the past 30 days^[3].